Edition:
United States

Karo Pharma AB (KARO.ST)

KARO.ST on Stockholm Stock Exchange

25.50SEK
23 May 2018
Change (% chg)

-0.10kr (-0.39%)
Prev Close
25.60kr
Open
25.65kr
Day's High
25.65kr
Day's Low
25.30kr
Volume
1,205,910
Avg. Vol
446,250
52-wk High
41.68kr
52-wk Low
25.30kr

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 1,652.00 1,652.00 1,652.00 --
Year Ending Dec-19 1 2,027.00 2,027.00 2,027.00 --
Earnings (per share)
Year Ending Dec-18 1 1.67 1.67 1.67 --
Year Ending Dec-19 1 2.17 2.17 2.17 --
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 20.39 84.06 32.75
P/E High - Last 5 Yrs. 17.52 293.32 45.73
P/E Low - Last 5 Yrs. 17.52 91.63 24.23
Beta 0.71 0.90 0.88
Price to Sales (TTM) 7.06 110.95 5.71
Price to Book (MRQ) 3.08 13.58 5.37
Price to Tangible Book (MRQ) -- 14.04 6.94
Price to Cash Flow (TTM) 19.20 71.44 23.33
% Owned Institutions -- 12.71 2.16

Dividends

  Company industry sector
Dividend Yield 0.70 0.31 1.50
Dividend Yield - 5 Year Avg 0.35 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) 0.00 15.72 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 73.93 399.27 9.21
Sales (TTM) vs TTM 1 Yr. Ago 100.57 78.86 5.69
Sales - 5 Yr. Growth Rate -- 32.18 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago 541.36 25.14 19.38
EPS (TTM) vs TTM 1 Yr. Ago 278.13 -- --
EPS - 5 Yr. Growth Rate -- 39.01 10.77
Capital Spending - 5 Yr. Growth Rate 15.70 40.31 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.81 2.19
Current Ratio (MRQ) 2.25 5.29 2.98
LT Debt to Equity (MRQ) 45.78 22.98 12.17
Total Debt to Equity (MRQ) 45.78 24.63 16.44
Interest Coverage (TTM) -9.49 -99.39 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 50.37 40.04 54.45
Gross Margin - 5 Yr. Avg. -- 51.16 52.21
EBITD Margin (TTM) 28.58 -- --
EBITD - 5 Yr. Avg -36.86 -575.09 10.96
Operating Margin (TTM) 20.58 -718.94 4.73
Operating Margin - 5 Yr. Avg. -43.06 -596.41 6.40
Pre-Tax Margin (TTM) 14.24 -693.40 5.57
Pre-Tax Margin - 5 Yr. Avg. -44.64 -599.76 6.82
Net Profit Margin (TTM) 28.74 -694.62 1.87
Net Profit Margin - 5 Yr. Avg. -30.81 -602.62 3.09
Effective Tax Rate (TTM) -101.89 22.63 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.22 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 6,716,145 22,637,573 847,034,055
Net Income/Employee (TTM) 1,930,536 2,973,815 99,640,144
Receivable Turnover (TTM) -- 20.17 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.37 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 10.69 -1.09 10.95
Return on Assets - 5 Yr. Avg. -9.05 -0.58 12.32
Return on Investment (TTM) 11.70 1.57 14.38
Return on Investment - 5 Yr. Avg. -13.05 2.21 16.11
Return on Equity (TTM) 15.82 2.43 16.07
Return on Equity - 5 Yr. Avg. -18.16 3.09 17.39
  1 Year 3 Year 5 Year
Sales % 402.58 94.73 --
EPS (TTM) % 192.15 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Karo Pharma AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 3.65 -- 99 53
13 Week -2.93 -- 90 65
26 Week 19.15 -- 99 77
52 Week 13.66 -- 99 50
YTD 51.68 -- 99 58
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 3.32%
# of Holders: 14
Total Shares Held: 5,448,510
3 Mo. Net Change: 552,174
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 10
# Reduced Positions: 0
# Net Buyers: 10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.